BioNTech Cell & Gene Therapies GmbH;TRON - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH
发明人:
Sahin, Ugur,Türeci, Özlem,Omokoko, Tana,Simon, Petra
申请号:
AU2016206329
公开号:
AU2016206329B2
申请日:
2016.07.21
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
#$%^&*AU2016206329B220171214.pdf#####ABSTRACT The present disclosure relates to efficient methods for providing antigen-specific lymphoid cells. These lymphoid cells may be sued to provide antigen specific T cell receptors having a defined MHC restriction and to identify immunologically relevant T cell epitopes. Furthermore, the present invention relates to antigen-specific T cell receptors and T cell epitopes and their use in immunotherapy.